InvestorsHub on MSN
Abivax shares gain after 22 scientific abstracts accepted for ECCO 2026
Abivax SA ADR (NASDAQ:ABVX) shares rose 2.6% in premarket trading on Thursday after the clinical-stage biotechnology company announced that 22 scientific abstracts have been accepted for presentation ...
Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, in partnership with Hitachi High-Tech Corporation (HHT) announces the presentation of high resolution structural variation ...
16hon MSN
India Needs A One Health Approach To Prepare For Future Pandemics, Says ICMR Director General
India needs a robust One Health approach and effective measures to combat future pandemics, said Dr. Rajiv Bahl, Director ...
Abivax SA ADR (NASDAQ:ABVX) stock rose 2.6% in premarket trading Thursday after the clinical-stage biotechnology company announced the acceptance of 22 scientific ...
Zonal Display Your Talent 2024-25’ being organized by the Department of Students Welfare, University of Jammu, the events of ...
Amarillo Globe-News on MSN
Center City invites Hoof Prints horse owners to Deck the Herd
The deadline has been extended to Dec. 23, and photos will vie for votes on Center City's Facebook page. Read more community ...
Now, with the European Union Health Technology Assessment (HTA) regulation coming into force as part of the required Joint Clinical Assessment (JCA) for oncology and advanced therapy medicinal ...
Bangkok Post on MSN
TSRI unites talent at Thailand Summit 2025
A nationwide effort to strengthen Thailand's science, research, and innovation ecosystem took centre stage with the launch of Thailand Talent Summit 2025, a major gathering designed to foster future ...
This weekend, Canberra will be coming alive as we count down the days until Christmas. From blockbuster exhibitions to ...
Title: Results from the randomized Phase 2 study (1801 Part 3B) of elraglusib plus gemcitabine/nab-paclitaxel (GnP) versus GnP in previously untreated metastatic pancreatic ductal adenocarcinoma ...
Kane Biotech Inc. (the "Company", "Kane" or "Kane Biotech") announces that today it has completed its previously announced non-brokered private placement offering (the "Offering") of common shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results